Wharton Healthcare conference offers key takeaways for innovation in pharma

At this year’s Wharton Health Care Business Conference, Redrawing the Curve, healthcare leaders opened up about health inequities and how the industry should adjust to address these inequities.

March 24, 2021

Digital Health

Telemedicine is here to stay: How the barriers are breaking down

Historically, telemedicine has been impeded by three main barriers: applicability, lack of insurance coverage, and technology. However, with COVID and innovation as accelerators, telemedicine is breaking through.

February 3, 2021

Digital Health

Digital Health in 2021 A.C. [After Covid]

HealthXL's newest blog post featured perspectives from ER's Bernice Ma and Todd Kolm on the future of Digital Health in 2021 after COVID-19.

January 18, 2021

Digital Health

Realizing the Promise of Digital Health Partnerships

Why have commercial life sciences, with a track record of going it alone, pivoted to partnerships with the Digital Health Ecosystem? How might a life science marketer get their organization primed for more/better partnering? How is the success of a partnership measured? What are some of the key watchouts in partnering?

December 18, 2020

Digital Health

ER contributes to The Digital Health Coalition’s newest POV: Mapping out your Privacy-First Marketing Strategy

Focused on privacy-first marketing strategy, DHC captures input from 20 leading digital marketing experts including Alison Hoskinson who provided her thoughts on the future of publisher-owned first-party data.

December 1, 2020

Digital Health

The Evolution of Social Determinants of Health during COVID-19

Social determinants of health (SDoH) are conditions in the places where people live, learn, work, and play that affect a wide range of health and quality-of life-risks and outcomes. You’ve probably seen or read the term in headlines, presented at conferences, or discussed at roundtables and meetings, but rarely mentioned in the coverage of SDoH is the pivotal role that pharma can play. Many leading pharmaceutical manufacturers have launched initiatives and partnerships aimed at addressing the impact of SDOH on health outcomes.

November 13, 2020

Digital Innovation

What Happens When 3rd-Party Cookies Expire?

The demise of third-party cookies will have significant implications for digital marketers. In this Pharma Marketing Network post, ER's Alison Hoskinson explains what's happening and how digital marketers for pharma brands will adapt.

August 27, 2020

Digital Health

Social Determinants, The Causes of the Causes

The social determinants of health are the conditions in which people are born, grow, live, work and age.1 You’ve probably seen or read the term in headlines, presented at conferences, or discussed at roundtables and meeting, but how are social determinants of health (SDoH) relevant to pharma?

October 23, 2019

Digital Innovation

PM360 Focus on New Technologies

PM360 asked the industry’s brightest which new technologies are having the most impact on marketers and how they need to adjust. ER's own Brandi Ascione shared her perspective.

October 11, 2019

Digital Health

Finding the right partner: Pharma and Digital Health

Digital health is all the buzz these days, but how do you know which digital health opportunity is the best one to pursue for your brand or organization? Based on our experience working with our life science clients to partner and execute digital health programs, here are a few considerations for a successful partnership:

October 1, 2019

How can we help?

Let us know what’s keeping you up at night and we’ll set up a conversation. No pitch. No sell.